Medications

AstraZeneca suffers diabetes drug setback for COVID

British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.

Diseases, Conditions, Syndromes

New test predicts sepsis soon after infection

In a potential paradigm change for sepsis diagnostics, a new test predicted sepsis soon after infection in mice—well before blood clotting and organ failure—enabling early antibiotic treatment and markedly increased survival. ...

Cardiology

Artery calcification more common in night owls, shows study

Artery calcification is almost twice as common in night owls compared to early birds, according to a study from the University of Gothenburg, Sweden. Circadian rhythm appears to be particularly important for the heart and ...

Cardiology

Artificial blood vessels become resistant to thrombosis

Scientists from ITMO University have developed artificial blood vessels that are not susceptible to blood clot formation. The achievement was enabled by a next-generation, drug-containing coating applied to the inner surface ...

Diseases, Conditions, Syndromes

What do heart patients need to know about COVID-19 now?

In the months since COVID-19 emerged, medical experts have learned a lot about the threat it poses to people with issues such as high blood pressure, diabetes, obesity or cardiovascular disease.

Vaccination

Chile limits use of AstraZeneca after clot case

Chile on Thursday became the latest country to limit use of the AstraZeneca coronavirus vaccine, linked to rare blood clots, when a 31-year-old man developed thrombosis after being immunized.

page 32 from 40